// App-Quantinova.ai

e15124 : Association of chemotherapy induced neutropenia at 1-month mark (CIN-1-month) and overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A Cohort study.

Researchers

Presenter

  • Pashtoon Murtaza Kasi

Principal Investigators

  • Daisuke Kotani

  • Michael Cecchini

  • Kohei Shitara

  • Atsushi Ohtsu

  • Ramesh K. Ramanathan

  • Howard S. Hochster

  • Axel Grothey

  • Takayuki Yoshino

Medical Centers

  • Mayo School of Graduate Medcl Education, Rochester, MN

  • National Cancer Center, EPOC, Chiba, Japan

  • Yale University, New Haven, CT

  • Depertment of Surgical Oncology, National Cancer Center Hospital East, Chiba, Japan

  • Mayo Clinic Cancer Center, Scottsdale, AZ

  • Department of Medical Oncology, Yale University School of Medicine, New Haven, CT

  • Mayo Clinic, Rochester, MN

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Neutropenia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • TAS102

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved